Quick Reference: Treating Patients With Advanced HCC

Download this clinical resource PDF reviewing best practices in the management of patients with advanced hepatocellular carcinoma.
Format: Adobe Acrobat (.pdf)
File Size: 98 KB
Released: October 30, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
AstraZeneca
Genentech, a member of the Roche Group
Lilly

For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

Related Content

From Clinical Care Options (CCO), watch video featuring expert perspectives on the use of immunotherapy for HCC

Lipika Goyal, MD Amit G. Singal, MD, MS Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: November 24, 2020 Expired: November 23, 2021

In slides from Clinical Care Options (CCO), experts provide insights on the optimal treatment of advanced HCC

Mark Yarchoan, MD Released: November 19, 2020

Review an expert commentary from Clinical Care Options (CCO) on choosing treatment for patients with HCC and Child-Pugh B cirrhosis

Mark Yarchoan, MD Released: November 18, 2020

Video of expert discussion on assessing HER2 status and using HER2-targeted agents for gastrointestinal cancers, from Clinical Care Options (CCO)

Mark D. Pegram, MD
Program Director
Michael F. Press, MD, PhD
Program Director
Axel Grothey Headshot Axel Grothey, MD
Physicians: maximum of 0.75 AMA PRA Category 1 Credits ABIM MOC: maximum of 0.75 Medical Knowledge MOC point(s) ABPath MOC: maximum of 0.75 Lifelong Learning (Part II) and Self-Assessment Module (SAM) point(s) Released: November 2, 2020 Expired: November 1, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue